Clinical implications of controlled attenuation parameter in a health check-up cohort

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

(2017) Thomas Karlas et al.   JOURNAL OF HEPATOLOGY

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography

(2016) Kento Imajo et al.   GASTROENTEROLOGY

Non-invasive diagnosis of hepatic steatosis

(2016) Christiane Stern et al.   Hepatology International

Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease

(2016) Victor de Lédinghen et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program

(2016) Pin-Nan Cheng et al.   MEDICINE

Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

(2016) Ivana Mikolasevic et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome

(2015) Amedeo Lonardo et al.   DIGESTIVE AND LIVER DISEASE

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

(2015) Raymond Kwok et al.   GUT

Noninvasive detection of hepatic steatosis in patients without ultrasonographic evidence of fatty liver using the controlled attenuation parameter evaluated with transient elastography

(2013) Yusuf Yilmaz et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound

(2013) Sofia Carvalhana et al.   LIVER INTERNATIONAL

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

(2012) Naga Chalasani et al.   GASTROENTEROLOGY

Determination of reliability criteria for liver stiffness evaluation by transient elastography

(2012) Jérôme Boursier et al.   HEPATOLOGY

Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography

(2012) Victor Lédinghen et al.   LIVER INTERNATIONAL

Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography

(2012) Robert P. Myers et al.   LIVER INTERNATIONAL

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

(2011) G. Vernon et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C

(2011) M. Sasso et al.   JOURNAL OF VIRAL HEPATITIS

Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes

(2010) Magali Sasso et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study

(2009) Srinivasan Dasarathy et al.   JOURNAL OF HEPATOLOGY

Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver

(2008) Nila Rafiq et al.   Clinical Gastroenterology and Hepatology